10x Genomics Inc.
(TXG) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
15.60
0.22%
After-hours Jan 03, 2025, 05:08 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | 618.73M | 516.41M | 490.49M | 298.85M | 245.89M | 146.31M | 71.08M |
Cost of Revenue | 209.41M | 120.39M | 74.09M | 58.47M | 61.03M | 28.66M | 10.56M |
Gross Profit | 409.31M | 396.02M | 416.40M | 240.38M | 184.86M | 117.65M | 60.52M |
Operating Income | -194.95M | -167.94M | -52.91M | -85.32M | -29.07M | -110.76M | -18.38M |
Interest Income | 16.91M | 6.65M | 206.00K | 1.53M | 2.81M | 1.02M | 308.00K |
Pretax Income | -248.76M | -161.97M | -53.72M | -534.48M | -31.03M | -112.40M | -18.74M |
Net Income | -255.10M | -166.00M | -58.22M | -542.73M | -31.25M | -112.48M | -18.76M |
Selling & General & Admin | 343.33M | 298.30M | 257.56M | 202.33M | 130.83M | 87.94M | 46.74M |
Research & Development | 270.33M | 265.67M | 211.75M | 123.38M | 83.10M | 47.54M | 32.16M |
Other Expenses | n/a | -198.00K | -802.00K | 1.34M | -186.00K | -249.00K | 137.00K |
Operating Expenses | 674.95M | 563.97M | 469.31M | 325.70M | 213.93M | 135.47M | 78.90M |
Interest Expense | 33.00K | 476.00K | 866.00K | 1.68M | 3.08M | 2.41M | 811.00K |
Selling & Marketing Expenses | 3.30M | 3.70M | 4.70M | 1.90M | 1.50M | 700.00K | 200.00K |
Cost & Expenses | 884.36M | 684.35M | 543.40M | 384.17M | 274.96M | 164.13M | 89.46M |
Income Tax | 6.34M | 4.03M | 4.51M | 8.26M | 218.00K | 87.00K | 21.00K |
Shares Outstanding (Basic) | 117.17M | 113.86M | 110.35M | 101.15M | 39.06M | 13.39M | 11.59M |
Shares Outstanding (Diluted) | 117.17M | 113.86M | 110.35M | 101.15M | 39.09M | 13.39M | 11.59M |
EPS (Basic) | -2.18 | -1.46 | -0.53 | -5.37 | -0.8 | -8.4 | -1.62 |
EPS (Diluted) | -2.18 | -1.46 | -0.53 | -5.37 | -0.8 | -8.4 | -1.62 |
EBITDA | -205.11M | -128.49M | -24.59M | -513.77M | -20.89M | -106.08M | -13.63M |
Depreciation & Amortization | 43.62M | 33.01M | 28.25M | 19.02M | 7.07M | 3.90M | 4.30M |